Royalty Report: Drugs, Nutraceutical, Food – Collection: 422

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Drugs
  • Nutraceutical
  • Food
  • Delivery
  • Healthcare
  • Supplements
  • Pharmaceuticals
  • Disease
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 422

License Grant
The University grants to Company a world-wide exclusive license under Patent Rights and Technical Information, with the right to grant sublicensees, to make, have made, use, sell, offer for sale, export, import and otherwise deal with Licensed Product,  for application thereof to dietary supplements and pharmaceutical products, including over-the-counter products, prescription drugs, OTC drugs and generic drugs.
License Property
Product shall mean (i) any dietary supplement (as defined in the 1994 Dietary Supplement and Health Education Act) (referred to herein as a Supplement); (ii) any drug which can be purchased by the general public without a prescription (referred to herein as OTC Drug); and (iii) any prescription drug (whether existing at the time of this Agreement or yet to be discovered).

Patent Application 09/037,096 and PCT Application PCT/US99/04508 related thereto, for application thereof to dietary supplements and pharmaceutical products, including over-the-counter products, prescription drugs, OTC drugs and generic drugs.

IPSCIO Record ID: 243441

License Grant
The parties agree that the Original License should be further amended and restated in its entirety.

The University grants a world-wide exclusive license under patent rights and technical information, with the right to grant sub licenses, to make, have made, use, sell, offer for sale, export, import and otherwise deal with Licensed Product. This license shall be perpetual.

License Property
The Patent Application 08/958,470 and technical information related thereto, are for application thereof to dietary supplements and pharmaceutical products, including over-the-counter products, prescription drugs, OTC drugs and generic drugs.

The Product shall mean
– any dietary supplement,as defined in the 1994 Dietary Supplement and Health Education Act;
– any drug which can be purchased by the general public without a prescription, referred to as an OTC Drug; and,
– any prescription drug, whether existing at the time of this Agreement or yet to be discovered.

Field of Use
The technology is for application to dietary supplements and pharmaceutical products, including over-the-counter products, prescription drugs, OTC drugs and generic drugs.

The new technology has been shown to be rugged and robust during in-vitro studies on a wide range of established pharmaceuticals, such as nifedipine, theophylline, propanolol, diltiazem, and verapamil, as well as OTC and nutritional supplements such as pseudoephedrine, glucosamine and niacin.

Licensee has applied materials science, colloid chemistry and biopharmaceutics in the development of these simple monolithic matrix systems collectively referred to as 'self-correcting matrix delivery systems.'
These approaches use the conventional tableting technologies to form swellable, erodible matrix tablets, caplets or capsules that can potentially yield first-order, bimodal and zero-order drug release profiles. In addition any combinations of soluble, highly soluble, insoluble, low drug dose, high drug load and drug combinations can be easily formulated with these technologies.

IPSCIO Record ID: 173732

License Grant
University and Licensee wish to amend the License Agreement.  This amendment modifies terms of the agreement including the royalty.
License Property
The agreement includes Products which are Pharmaceuticals (Rx), Over-The-Counter (OTC), and Dietary Supplement Health and Education Act (DSHEA) extracts or compounds.

Unlike the traditional drug development process of identifying and synthesizing single bioactive molecules from plant sources, the Company's core technologies were developed based on empirical data that suggests that the health benefits and safe usage of certain plant-derived therapeutics might be the result of the natural combination of multiple molecules found in the plant extract and that single molecules, in isolation, may not replicate the natural plants' effectiveness. The PharmaPrint Process technology enables the Company to identify and quantify the bioactives within plant sources that are believed to provide therapeutic benefits and produce dietary supplements and pharmaceuticals having consistent batch-to-batch quantities and ratios of these bioactives.

Field of Use
This agreement is for the pharmaceutical and dietary health care industry.

IPSCIO Record ID: 4735

License Grant
The Licensor was assigned the License agreement related to dietary supplements and drugs, by the original Licensor in a Stock Purchase Agreement.
License Property
Dietary supplements including glucan and fulvic acid and herbal enhanced analgesic formulations.
Field of Use
Licensee is a biotechnology company engaged in the research and development, marketing and sale of lifestyle, dietary supplements and drugs.

IPSCIO Record ID: 26627

License Grant
The Licensor grants a limited license to use CDT to manufacture, package, ship, distribute and sell the Products to Customers, as defined below, in the United States in accordance with and for the Term of this Agreement (the License).
License Property
Our CDT (Controlled Delivery Technology) platform currently consists of three patented drug delivery technologies for prescription drugs, over-the-counter (OTC) products, and nutraceuticals.  The CDT platform is used in solid oral dosage forms, the preferred route for drug administration. This technology is designed to produce tablets or capsules that release their active agents predictably and programmable over a specified time frame of up to 24 hours.
Field of Use
Licensee manufactures and distributes vitamins and dietary and nutritional supplements for various third party customers.

IPSCIO Record ID: 7233

License Grant
The Canadian Licensor grants the Canadian Licensee, a subsidiary, an exclusive, non-transferable license for the term and in the worldwide territory to use the Licensed Intellectual Property solely within the Licensed Field and where it relates to the development and commercialization of Licensed Products.
License Property
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.  
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.

Nutraceutical Products means any dietary supplement or functional food that has proven health and medical benefits.  Dietary Supplement means a product isolated or purified from foods that is generally sold in medicinal forms not usually associated with food; a dietary supplement is demonstrated to have a physiological benefit to maintain healthy physiological systems.  Functional Food is similar in appearance to, or may be conventional food, is consumed as part of a usual diet, and is demonstrated to have physiological benefits to maintain healthy physiological systems beyond basic nutritional functions.

Nutrigenomic Products means Nutraceuticals designed to interact with specific genes to reduce the risk of common chronic diseases by altering the expression of genes and the structure of an individual’s genome.

Field of Use
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.  
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.

The Licensee is a Canadian-based biopharmaceutical company dedicated in the research, development and commercialization of innovative proprietary active pharmaceutical ingredients for the management of cardiometabolic disorders, from prevention to treatment, bridging the treatment gap in lipid management.

IPSCIO Record ID: 7003

License Grant
The Licensor will grant to Licensee a perpetual, exclusive, worldwide license under patents and associated know-how and other intellectual property rights to develop, manufacture and commercialize probiotics for use as dietary supplements for human consumption or human use over-the-counter without a prescription or otherwise in the vitamins, minerals and supplements market (including foods or beverages marketed as supplements).

The Licensor hereby grants to Licensee, and Licensee hereby accepts, an exclusive, worldwide, license under the Licensed Patents to research, develop, improve, produce, manufacture, have manufactured, market, promote, offer to sell, sell, use, import, distribute and commercialize Probiotics and Products and otherwise exploit the Licensed Patents, in each case, for use in the Licensed Field of Use (the Patent License).

The Licensor grants to Licensee, an exclusive, worldwide License to use the Licensed Trademarks on any Product for use in the Field of Use including the use of BC30.

The Licensor grants an exclusive, worldwide License under the Licensed Copyrights.

License Property
The Licensor transferred certain inventory, receivables and intellectual property and certain liabilities relating to probiotic brands Sustenex and Digestive Advantage.
Field of Use
The rights granted apply for the use as dietary supplements for human consumption or human use over-the-counter without a prescription or otherwise in the vitamins, minerals and supplements market.

In connection Asset Purchase, Licensee wishes to obtain an exclusive, Worldwide License to certain Intellectual Property Rights including all Patents Controlled by the Licensor including all Patents that claim or otherwise cover, any Probiotic or Product, or the research, development, manufacture, use or commercialization thereof.

IPSCIO Record ID: 3311

License Grant
In the six months ended June 30, 2014, the Licensee incurred $88 thousand of expense based on the Research and Royalty Agreement with the Licensor, under which the Licensee is obligated to pay a royalty on all Anatabloc® sales.
License Property
Anatabine is used as a dietary supplement and as a drug. The dietary supplements are known as Anatabloc.

IPSCIO Record ID: 5375

License Grant
The University hereby grants to Licensee a semi-exclusive license under the University interest in the University Patent Rights in the Licensed Field to make, have made, use, and sell Licensed Products and to practice Licensed Method.
License Property
Licensed Product (s) means any material or product or kit, or any service, process, or procedure that (1) either is covered by the University Patent Rights or whose manufacture, use, or sale would constitute, but for the license granted to Licensee pursuant to this Agreement, an infringement of any claim within the University Patent Rights (U.S. Patent Application Numbers 94-0809-1, 95-0315-1 and 95-0413-1) or (2) is discovered, developed, made, sold, registered, or practiced using Licensed Method or which may be used to practice the Licensed Method, in whole or in part.
Field of Use
Certain inventions relating to the development of phytoremediation technology, with application to the field of nutritional and dietary supplements, were made in the course of research sponsored by Licensee.

Licensed Field  means the use for nutritional and dietary supplements.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.